NIGMS Technology Development Programs (R21 and R01)

NIGMS Technology Development Programs (R21 and R01): The technology development R21 and R01 notice of funding opportunities (NOFOs) support technological innovations to advance biomedical research. Example technologies, which might originate from biomedical, engineering, or physical sciences disciplines, include instruments, devices, processes, algorithms, software, chemicals, biomolecules, or cells that have potential value for generating new basic biomedical research. The NOFOs support the earliest stages of technology development, establishing feasibility/proof of concept, and prototype validation, and do not support applications that address new biological questions. Investigators are strongly encouraged to contact program staff ( NIGMS_TechDev@nigms.nih.gov ) prior to and in preparation for submitting an application to these programs.

Technology Stage

Funding Opportunity

Proof of Concept and Value
Exploratory Research / Technology Feasibility

Right arrow graphic.

Technology Development R21
Innovative Concepts
Awards

Down arrow graphic.

Prototype Validation
Iterative Technology R&D / Validation Studies

Right arrow graphic.

Technology Development R01
Verification of Utility
Awards

Down arrow graphic.

Addressing Biological Questions
Applied technology R&D and Dissemination

Right arrow graphic.

MIRA
Research Program
Parent R01
Testing Biological Questions

Down arrow graphic.

Late-Stage Technology Optimization for Broad Utility and Self-Sustaining Dissemination

Right arrow graphic.

Biomedical Technology Optimization & Dissemination RM1 Awards

Info Icon Frequently Asked Questions

Program Overview Video

Send your questions about the programs to the NIGMS tech dev contact mailbox .

Technology Commercialization through Small Business​ ​

Concept to Clinic: Commercializing Innovation Program